Kathleen Goin, Chief Operating Officer at PALVELLA THERAPEUTICS, INC. (PVLA), sold 4,302 shares at $125.96 ($547K) on 2026-04-15, disclosed to the SEC on 2026-04-17.
Scheduled sale ($547k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.96 | 1,502 | $189K | 34.6% |
| 2 | $127.13 | 1,500 | $191K | 34.8% |
| 3 | $128.23 | 561 | $72K | 13.1% |
| 4 | $129.17 | 639 | $83K | 15.1% |
| 5 | $130.33 | 100 | $13K | 2.4% |
| Total | $127.24 avg | 4,302 |
| $547K |
| 100% |
| Filing → |
| PVLA | SELL | 2026-07-17 | $642K | — | Filing → |
| PVLA | SELL | 2026-06-22 | $476K | — | Filing → |
| PVLA | SELL | 2026-05-22 | $476K | — | Filing → |